Islet autoantibody positivity in overweight and obese adults with type 2 diabetes.
Ontology highlight
ABSTRACT: Islet autoantibodies are typically associated with type 1 diabetes, but have been found in patients diagnosed with type 2 diabetes in whom they are associated with lower adiposity. The significance of autoantibody positivity in overweight and obese patients is not well understood. The aim of this study was to determine the prevalence and clinical significance of islet autoantibodies in overweight/obese adults diagnosed with type 2 diabetes. This study includes 204 participants at one site of the multicenter Look AHEAD (Action for Health in Diabetes) trial (ClinicalTrials.gov identifier: NCT00017953) which randomized overweight/obese adults diagnosed with type 2 diabetes to an intensive lifestyle intervention or diabetes support and education. We measured antibodies to glutamic acid decarbo
SUBMITTER: Pilla SJ
PROVIDER: S-EPMC6362362 | biostudies-literature | 2018 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA